Consent is an important consideration if introducing testing. A patient expert highlighted that people who have had a stroke often have severe cognitive impairment, may have difficulty with their ...

Obtaining molecular genotyping results before first-line treatment resulted in better outcomes for patients with non-small cell lung cancer, an expert explained. A recent study showed that undergoing ...

Clinicians should offer a genetic test to people who have had an ischaemic stroke or transient ischaemic attack to determine whether they can be treated with the drug clopidogrel to reduce the risk of ...

FDA this week approved its first genotyping test for patients with hepatitis C virus (HCV), Abbott’s RealTime HCV Genotype II. The test can differentiate genotypes ...

In a July 23 Instagram video, Dr Vass, a ‘longevity doctor and MD trained at Cornell', spoke about the APOE Genotype Test, a tool that can provide insights into an individual's risk of developing ...

Patients with acute ischaemic stroke or transient ischaemic attack (TIA) are less likely to have secondary vascular events when their clinicians test them for genetic variants conferring resistance to ...

Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer We performed a retrospective ...

People who have had a stroke are at increased risk of further occlusive vascular events, such as recurrent stroke or myocardial infarction. For people who have had a non‑cardioembolic ischaemic stroke ...